240 related articles for article (PubMed ID: 16083874)
21. Azimilide (NE-10064) can prolong or shorten the action potential duration in canine ventricular myocytes: dependence on blockade of K, Ca, and Na channels.
Yao JA; Tseng GN
J Cardiovasc Electrophysiol; 1997 Feb; 8(2):184-98. PubMed ID: 9048249
[TBL] [Abstract][Full Text] [Related]
22. Phase 2 early afterdepolarization as a trigger of polymorphic ventricular tachycardia in acquired long-QT syndrome : direct evidence from intracellular recordings in the intact left ventricular wall.
Yan GX; Wu Y; Liu T; Wang J; Marinchak RA; Kowey PR
Circulation; 2001 Jun; 103(23):2851-6. PubMed ID: 11401944
[TBL] [Abstract][Full Text] [Related]
23. Propofol decreases reperfusion-induced arrhythmias in a model of "border zone" between normal and ischemic-reperfused guinea pig myocardium.
Hanouz JL; Yvon A; Flais F; Rouet R; Ducouret P; Bricard H; Gérard JL
Anesth Analg; 2003 Nov; 97(5):1230-1238. PubMed ID: 14570628
[TBL] [Abstract][Full Text] [Related]
24. The influence of extracellular acidosis on the effect of IKr blockers.
Lin C; Ke X; Cvetanovic I; Ranade V; Somberg J
J Cardiovasc Pharmacol Ther; 2005 Mar; 10(1):67-76. PubMed ID: 15821840
[TBL] [Abstract][Full Text] [Related]
25. The class III effect of azimilide is not associated with reverse use-dependence in open-chest dogs.
Qi XQ; Newman D; Dorian P
J Cardiovasc Pharmacol; 1999 Dec; 34(6):898-903. PubMed ID: 10598136
[TBL] [Abstract][Full Text] [Related]
26. Impact of glucose concentration on cardiac ventricular repolarization under I Kr/I Ks blocking agents.
Hreiche R; Plante I; David LP; Simard C; Turgeon J; Drolet B
J Mol Cell Cardiol; 2009 Aug; 47(2):210-20. PubMed ID: 19233195
[TBL] [Abstract][Full Text] [Related]
27. Effects of azimilide, a KV(r) and KV(s) blocker, on canine ventricular arrhythmia models.
Xue Y; Yamada C; Chino D; Hashimoto K
Eur J Pharmacol; 1999 Jul; 376(1-2):27-35. PubMed ID: 10440086
[TBL] [Abstract][Full Text] [Related]
28. Use-dependent effects of the class III antiarrhythmic agent NE-10064 (azimilide) on cardiac repolarization: block of delayed rectifier potassium and L-type calcium currents.
Fermini B; Jurkiewicz NK; Jow B; Guinosso PJ; Baskin EP; Lynch JJ; Salata JJ
J Cardiovasc Pharmacol; 1995 Aug; 26(2):259-71. PubMed ID: 7475051
[TBL] [Abstract][Full Text] [Related]
29. Electrophysiological and antiarrhythmic properties of potassium canrenoate during myocardial ischemia-reperfusion.
Alexandre J; Beygui F; Puddu PE; Manrique A; Rouet R; Milliez P
J Cardiovasc Pharmacol Ther; 2015 May; 20(3):313-21. PubMed ID: 25389106
[TBL] [Abstract][Full Text] [Related]
30. Comparison of the rate-dependent properties of the class III antiarrhythmic agents azimilide (NE-10064) and E-4031: considerations on the mechanism of reverse rate-dependent action potential prolongation.
Groh WJ; Gibson KJ; Maylie JG
J Cardiovasc Electrophysiol; 1997 May; 8(5):529-36. PubMed ID: 9160229
[TBL] [Abstract][Full Text] [Related]
31. Azimilide dihydrochloride, a novel antiarrhythmic agent.
Karam R; Marcello S; Brooks RR; Corey AE; Moore A
Am J Cardiol; 1998 Mar; 81(6A):40D-46D. PubMed ID: 9537222
[TBL] [Abstract][Full Text] [Related]
32. Levosimendan: effects of a calcium sensitizer on function and arrhythmias and cyclic nucleotide levels during ischemia/reperfusion in the Langendorff-perfused guinea pig heart.
Du Toit EF; Muller CA; McCarthy J; Opie LH
J Pharmacol Exp Ther; 1999 Aug; 290(2):505-14. PubMed ID: 10411556
[TBL] [Abstract][Full Text] [Related]
33. The electrophysiological effects of racemic ketamine and etomidate in an in vitro model of "border zone" between normal and ischemic/reperfused guinea pig myocardium.
Hanouz JL; Repesse Y; Zhu L; Lemoine S; Rouet R; Sallé L; Plaud B; Gérard JL
Anesth Analg; 2008 Feb; 106(2):365-70, table of contents. PubMed ID: 18227286
[TBL] [Abstract][Full Text] [Related]
34. Assessment of the proarrhythmic potential of the novel antiarrhythmic agent AZD7009 and dofetilide in experimental models of torsades de pointes.
Wu Y; Carlsson L; Liu T; Kowey PR; Yan GX
J Cardiovasc Electrophysiol; 2005 Aug; 16(8):898-904. PubMed ID: 16101634
[TBL] [Abstract][Full Text] [Related]
35. Antiarrhythmic and electrophysiological effects of GYKI-16638, a novel N-(phenoxyalkyl)-N-phenylalkylamine, in rabbits.
Baczkó I; El-Reyani NE; Farkas A; Virág L; Iost N; Leprán I; Mátyus P; Varró A; Papp JG
Eur J Pharmacol; 2000 Sep; 404(1-2):181-90. PubMed ID: 10980278
[TBL] [Abstract][Full Text] [Related]
36. Proarrhythmic effects of DL- and D-sotalol on the "border zone" between normal and ischemic regions of isolated ventricular myocardium and antiarrhythmic effects on reperfusion.
Picard S; Rouet R; Monti F; Puddu PE; Ducouret P; Flais F; Libersa C; Gérard JL
J Cardiovasc Pharmacol; 1998 Jan; 31(1):126-39. PubMed ID: 9456287
[TBL] [Abstract][Full Text] [Related]
37. IKs blockade reduces dispersion of repolarization in heart failure.
Pajouh M; Wilson LD; Poelzing S; Johnson NJ; Rosenbaum DS
Heart Rhythm; 2005 Jul; 2(7):731-8. PubMed ID: 15992730
[TBL] [Abstract][Full Text] [Related]
38. Impaired epicardial activation-repolarization coupling contributes to the proarrhythmic effects of hypokalaemia and dofetilide in guinea pig ventricles.
Osadchii OE
Acta Physiol (Oxf); 2014 May; 211(1):48-60. PubMed ID: 24533513
[TBL] [Abstract][Full Text] [Related]
39. Effects of azimilide and d,l-sotalol on the heart rate and blood pressure response to isoproterenol in anesthetized rats.
Mittelstadt SW; Maynard AE; Benn DR; Lowe ER; Kostreva DR
Cardiovasc Drugs Ther; 1997 Sep; 11(4):591-8. PubMed ID: 9358964
[TBL] [Abstract][Full Text] [Related]
40. Effects of lidocaine on reperfusion arrhythmias and electrophysiological properties in an isolated ventricular muscle model of ischemia and reperfusion.
Li GR; Ferrier GR
J Pharmacol Exp Ther; 1991 Jun; 257(3):997-1004. PubMed ID: 2046029
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
